Point72 Hong Kong’s Mustang Bio MBIO Stock Holding History

Point72 Hong Kong’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	-$2K	–	2050
2020 Q4	$2K	Buy	+1	New	+$2.39K	﹤0.01%	1646
2020 Q3	–	Sell	-7	Closed	-$18K	–	1385
2020 Q2	$18K	Buy	+7	New	+$16.4K	﹤0.01%	909

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's MBIO Position: Q1 2021 in Review

Point72 Hong Kong sold out of Mustang Bio (MBIO) in Q1 2021, closing a stake of 1 share — an estimated $2K sold.

Point72 Hong Kong first reported a position in MBIO in Q2 2020 and held it in 2 quarters. The position peaked at $18K in Q2 2020. 95 funds tracked by Wall St. Rank hold MBIO as of Q1 2021.

Point72 Hong Kong reported no remaining Mustang Bio position as of Q1 2021 after selling out during the quarter.
Point72 Hong Kong sold 1 Mustang Bio share in Q1 2021, an estimated $2K.
Point72 Hong Kong first reported a position in Mustang Bio in Q2 2020 and held it in 2 quarters.
Point72 Hong Kong's Mustang Bio position peaked at $18K in Q2 2020.
95 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2021.

Based on Point72 Hong Kong's 13F filing for Q1 2021, filed 17 May 2021.